XML 31 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   16,614,178        
Beginning balance at Dec. 31, 2020   $ 141,422        
Ending balance (in shares) at Dec. 31, 2021   0        
Ending balance at Dec. 31, 2021   $ 0        
Beginning balance (in shares) at Dec. 31, 2020     314,096      
Beginning balance at Dec. 31, 2020 $ (147,832)   $ 0 $ 239,826 $ 33 $ (387,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (36,080)         (36,080)
Unrealized loss on available-for-sale debt securities (305)       (305)  
Net exercise of Series B’ redeemable convertible preferred stock warrants (in shares)   213,941        
Net exercise of Series B’ redeemable convertible preferred stock warrants 0 $ 5,606        
Conversion of redeemable convertible preferred stock into common stock (in shares)   (16,828,119) (16,828,119)      
Conversion of redeemable convertible preferred stock into common stock (147,028) $ (147,028) $ (17) (147,011)    
Number of shares of common stock issued upon conversion of one share of redeemable convertible preferred stock (in shares)     185      
Net exercise of common stock warrants 0          
Issuance of common stock upon initial public offering, net of issuance costs and underwriting discount (in shares)     6,900,000      
Issuance of common stock upon initial public offering, net of issuance costs and underwriting discount of $11,813 $ 105,487   $ 7 105,480    
Issuance of common stock pursuant to stock option exercises (in shares) 300,768   300,768      
Issuance of common stock pursuant to stock option exercises $ 8     8    
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)     109,831      
Issuance of common stock pursuant to Employee Stock Purchase Plan 911     911    
Change in early exercise liability (2)     (2)    
Stock-based compensation $ 4,288     4,288    
Ending balance (in shares) at Dec. 31, 2021 24,452,999   24,452,999      
Ending balance at Dec. 31, 2021 $ 73,503   $ 24 497,522 (272) (423,771)
Ending balance (in shares) at Dec. 31, 2022   0        
Ending balance at Dec. 31, 2022   $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (47,082)         (47,082)
Unrealized loss on available-for-sale debt securities $ (836)       (836)  
Issuance of common stock pursuant to stock option exercises (in shares) 157,447   157,447      
Issuance of common stock pursuant to stock option exercises $ 4     4    
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)     284,758      
Issuance of common stock pursuant to Employee Stock Purchase Plan 894   $ 1 893    
Issuance of common stock upon vesting of restricted stock units (in shares)     194,705      
Issuance of common stock upon vesting of restricted stock units 0          
Shares withheld for taxes (in shares)     (8,436)      
Shares withheld for taxes (59)     (59)    
Repurchase of common stock (in shares)     (35,722)      
Repurchase of common stock 0          
Change in early exercise liability 4     4    
Stock-based compensation $ 8,349     8,349    
Ending balance (in shares) at Dec. 31, 2022 25,045,751   25,045,751      
Ending balance at Dec. 31, 2022 $ 34,777   $ 25 $ 506,713 $ (1,108) $ (470,853)